Drug intelligence / Profile preview

Equizym MCA

Development stage
Unknown
Lead developer
Kyberg Pharma
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Equizym MCA is an oral multi-ingredient dietary supplement manufactured by Kyberg Pharma. It is formulated as tablets containing a combination of plant-derived proteolytic enzymes (bromelain from pineapple and papain from papaya), a patented protein-rich lentil extract (Defensan®), selenium (as sodium selenite), and Vitamin B2 (riboflavin). Equizym MCA is used as a supportive or complementary nutritional supplement during and after chemotherapy, radiation therapy, or adjuvant hormone therapy (such as in breast cancer patients) to help compensate for nutritional deficiencies, support mucous membrane function, boost immune defense, and alleviate side effects like arthralgia and mucosal dryness.

Brand names
Equizym MCA
Other names
EquizymEquizym® MCAbromelain + papain + Lens culinaris lectin + riboflavin + sodium selenitebromelain + papain + lentil extract + riboflavin + sodium selenite

Beyond the preview

Go deeper on Equizym MCA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Equizym MCA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call